UNITED THERAPEUTICS Corp (UTHR)
Pharmaceutical Preparations · Healthcare · $23.1B
Intrinsic Value (Consensus)
$462.96
Current Price
$548.27
Margin of Safety
-15.6%
15.6% Above Intrinsic Value
Value: $463
Price: $548
Valuation Model Estimates
Current Price: $548.27
DCF (Discounted Cash Flow)
$699.31
Graham Number
$324.84
Earnings Power Value
$270.49
Relative Value (P/E)
$557.20
Dividend Discount Model
Not applicable
—
Consensus Value
$462.96
Model Assumptions
Discount Rate
10.3%
Growth Rate
13.1%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
67
Profitability
22/25
Strength
17/25
Valuation
9/25
Growth
19/25
Key Financials
- EPS (TTM)
- $27.86
- EPS (Forward)
- $31.50
- Book Value
- $168.33
- P/E Ratio
- 20.0
- Forward P/E
- 17.7
- PEG Ratio
- —
- ROE
- 18.8%
- Debt/Equity
- —
- Revenue Growth
- 10.6%
- Earnings Growth
- 13.1%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance